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Background. Previous studies have suggested that endothelins, a
family of 21 amino acid peptides with potent vasoconstrictive and
mitogenic properties, are involved in the pathogenesis of acute
and chronic renal failure. In addition, endothelin seems to play an
important role in mediating the nephrotoxic side effects of
cyclosporine A (CsA) and tacrolimus. The present study investi-
gated the production of endothelin-1 (ET-1) and endothelin-3
(ET-3) by bipolar differentiated rabbit proximal tubule cells (PT-1
cells), and the modulatory effect of CsA, tacrolimus, hepatocyte
growth factor (HGF) and epidermal growth factor (EGF) on
ET-1 and ET-3 release.
Methods. ET-1 and ET-3 mRNA was detected by RT-PCR,
immunoreactive endothelin was localized to PT-1 cells by immu-
nofluorescence staining with antibodies against ET-1 and ET-3.
ET-1 and ET-3 release into the culture medium was determined
by specific radioimmunoassays after solid phase extraction.
Results. PT-1 cells exhibited a time-dependent increase of ET-1
release up to an incubation period of 36 hours, whereas ET-3
release already reached a steady state level after four hours. PT-1
cells, cultured on filter membranes, released a significantly higher
amount of immunoreactive ET-1 into the basolateral compart-
ment than into the apical compartment. ET-3 release did not
differ significantly between the basolateral and the apical com-
partment. Supplementation of the cell culture medium with 10%
fetal calf serum induced a marked increase of the basolateral and
apical ET-1 release, whereas ET-3 release was only slightly
increased. CsA and tacrolimus (0.5 to 5000 mg/liter) induced a
significant, dose-dependent increase of ET-1 and ET-3 release by
PT-1 cells with a maximum stimulation at a CsA concentration of
500 mg/liter (P , 0.001) and a tacrolimus concentration of 50
mg/liter (P , 0.001). HGF and EGF (10210 to 1028 mol/liter)
exerted a significant (P , 0.001) dose-dependent inhibitory effect
on ET-1 release, whereas ET-3 release was not significantly
reduced. Coincubation of PT-1 cells with CsA or tacrolimus and
HGF or EGF also resulted in a marked reduction of ET-1 release.
Conclusions. The present data suggest that ET-1 and ET-3
release by cultured rabbit proximal tubule cells are regulated
differently, and that the stimulatory effect of CsA and tacrolimus
on ET-1 release is antagonized by HGF and EGF.
The endothelins are a family of peptides with potent
vasoactive and mitogenic properties. Endothelin-1 was
originally isolated from the supernatant of cultured porcine
aortic endothelial cells [1]. To date, three isoforms have
been identified, endothelin-1, -2 and -3 (ET-1, ET-2, ET-3),
and they are encoded by three separate genes [2]. Endo-
thelial cells seem to represent the main site of endothelin
production, however, endothelin synthesis has also been
localized to other cell types, including renal mesangial cells
[3], proximal tubule cells and collecting duct cells [4–6].
Endothelial cells have been shown to secrete ET-1 predom-
inantly into the basolateral compartment [7], and recently
published data suggest that renal proximal tubule and
collecting duct cells also exhibit a polar ET-1 secretion [8,
9]. In the present study, we investigated the basolateral and
apical ET-1 and ET-3 release by rabbit proximal tubule
cells (PT-1 cells).
Several studies have suggested an upregulation of endo-
thelin production in acute and chronic renal failure [10–
12]. An enhanced endothelin production seems also to be
involved in mediating the nephrotoxic side effects of cyclo-
sporine [13–15]. Recently published studies have demon-
strated a stimulatory effect of cyclosporine A (CsA) on
ET-1 production by cultured endothelial cells [16], cultured
mesangium cells [17, 18] and renal cortical epithelial cells
[19]. The present study investigated the effects of CsA and
the newer immunosuppressive agent tacrolimus on the
ET-1 and ET-3 release by cultured rabbit proximal tubule
cells. In addition, we investigated whether the basal and the
CsA- and tacrolimus-induced endothelin release is modu-
lated by renotropic factors, such as hepatocyte growth
factor (HGF) and epidermal growth factor (EGF), which
have been shown to stimulate renal tubular cell prolifera-
tion and to accelerate renal regeneration after drug-in-
duced and ischemia-induced renal injury [20–24].
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METHODS
Culture of rabbit proximal tubule cells
Rabbit proximal tubule (PT-1) cells were originally de-
rived from microdissected proximal tubule segments of
normal rabbits and immunoselected into a homogeneous
population. Cells were transfected with plasmid pSV2-
neoDNA (which contains the bacterial gene neo that
confers resistance to the toxic antibiotic G418) plus DNA
from the early region of SV40, containing the immortaliz-
ing large T antigen. PT-1 cells exhibit multiple morpholog-
ical and functional characteristics of differentiated proxi-
mal tubule epithelial cells. PT-1 cells stain positively for
cytokeratin and alkaline phosphatase, include a sodium-
coupled hexose transport system, and have apical microvilli
and lateral tight junctions as described previously [25, 26].
PT-1 cells were cultured in culture flasks and six well plates
in a humidified incubator (37°C, 95% air, 5% CO2).
Maintenance medium contained DMEM/HAM’S F-12
(1:1, Biochrom, Berlin, Germany), supplemented with ge-
neticin (G418, 1 mg/ml), penicillin (500 U/ml), streptomy-
cin (500 mg/ml), and 10% fetal calf serum (FCS).
Determination of endothelin-1 and endothelin-3 mRNA
ET-1 and ET-3 mRNA expression was investigated in
PT-1 cells, maintained in culture medium containing 5%
FCS. RNA extraction was performed using a High Pure
RNA Isolation Kit (Boehringer Mannheim, Mannheim,
Germany) according to the manufacturer’s instructions.
The concentration and purity of RNA was determined by
measuring the absorbance at 260 nm and 280 nm. After
DNA digestion (DNase I Amplification Grade, RNase-
free; Gibco, Eggenstein, Germany), reverse transcription
polymerase chain reaction (RT-PCR) was performed with
the Titany One Tube RT-PCR System (Boehringer Mann-
heim). Specific primers were synthesized (Interactiva, Ulm,
Germany) according to known prepro-ET-1 and ET-3
cDNA sequences [27, 28]. Prepro-ET-1 primer 1 (anti-
sense) was defined by bases 621 to 640, sequence 59-
CTGTTGCTGATGGCCTCCAA-39, primer 2 (sense) en-
compassed bases 201 to 220, sequence 59-ACAGGAGCG-
GAAAACCCAGG-39, ET-3 primer 1 (anti-sense) com-
prised bases 835 to 855, sequence 59-TGTTGATCCA-
GATGATGTCCA-39, and primer 2 (sense) was defined by
bases 579 to 596, sequence 59-GTGCCTTGCCCCCA-
GACT-39. The reverse transcription was performed at 50°C
for 30 minutes using 100 ng total RNA for detection of
ET-1 mRNA and 10 ng total RNA for detection of ET-3
mRNA. Up to 40 amplification cycles were performed
starting with denaturation at 94°C for 30 seconds (first cycle
3 min), followed by primer annealing at 54°C for 45
seconds, and extension at 68°C for one minute. The ex-
pected size of the RT-PCR product was 440 base pairs for
ET-1 and 276 base pairs for ET-3. RT-PCR products were
analyzed on a 1% agarose gel and visualized by staining
with ethidium bromide. To confirm that RT-PCR products
represent rabbit prepro-ET-1 and ET-3 encoding frag-
ments, PCR products were isolated from agarose gel with a
QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany)
and sequenced (Sequiserve, Vaterstetten, Germany; ABI
PRISM Dye Terminator, Perkin Elmer, Foster City, CA,
USA).
Immunofluorescence staining of cultured rabbit proximal
tubule cells
Cells were grown on glass slides. For detection of
endothelin-like immunoreactivity, cells were fixed with
methanol (6 min, 220°C). Unspecific staining was blocked
by incubation with porcine normal serum (1:10) for 30
minutes at room temperature. Cells were washed with
phosphate buffered saline (PBS) and incubated with anti-
bodies against ET-1 [1:100, monoclonal (mouse) anti-
endothelin 1 antibody; Dianova, Hamburg, Germany; cross
reactivity for ET-1 was 100%, ET-2 ,10%, and ET-3
,10%] and ET-3 (1:200, rabbit anti-endothelin 3; Phoenix
Pharmaceuticals, Mountain View, CA, USA; cross reactiv-
ity for ET-3 was 100%, ET-1 0.1%, and ET-2 0.1%) for two
hours at room temperature. Cells were washed with PBS
and incubated with biotinylated secondary antibodies [bio-
tinylated F(ab9)2 fragment of rabbit anti-mouse immuno-
globulins 1:400; biotinylated F(ab9)2 fragment of swine
anti-rabbit immunoglobulins 1:500; Dako, Hamburg, Ger-
many] for one hour at room temperature. After another
washing step, binding of the secondary antibody was de-
tected with streptavidin-Cy3 (1:300 for 1 hr at room
temperature; Rockland, Gilbertsville, PA, USA). Controls
included Western blots to demonstrate that anti-ET-1 and
anti-ET-3 antibodies react with specific bands of the pre-
dicted sizes for ET-1 and ET-3 as well as immunofluores-
cence staining of PT-1 cells with (a) anti-ET-1 and anti-
ET-3 antibodies, preabsorbed with the respective peptides
(1026 and 1025 mol/liter, 24 hr at 4°C) and (b) equivalent
concentrations of pre-immune serum instead of the pri-
mary antibody.
Investigation of the time course of endothelin-1 and
endothelin-3 release
The time course of endothelin release was determined in
PT-1 cells, cultured in six well plates (N 5 3) in culture
medium containing 5% FCS. Cell culture supernatants
were collected after 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 24, 36, 48 and
72 hours into EDTA containing tubes (1.2 mg/ml), imme-
diately frozen and stored at 280°C, until assayed. The
corresponding cell numbers were counted in a cell counting
chamber and controlled by an automatic cell counter
(Cell-Dyn 3500; auxiliary mode; Abbott, Abbott Park, IL,
USA).
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Investigation of polar secretion of endothelin-1 and
endothelin-3
For the investigation of polar endothelin secretion, cells
were grown in six well plates on filter membranes (pore size
0.4 mm; Becton Dickinson, Basel, Switzerland). Confluent
monolayers were incubated with cell culture medium con-
taining either 1% or 10% FCS (2 experiments, 3 wells
each). After an incubation period of 72 hours, cell culture
medium was collected from the basolateral and apical
compartments.
Incubation of proximal tubule cells with cyclosporine A,
tacrolimus and renotropic factors
PT-1 cells, cultured in six well plates in culture medium
supplemented with 5% FCS, were incubated for five days
with cyclosporine A (Sandimmun; Sandoz, Nu¨rnberg, Ger-
many) and tacrolimus (Prograf; Fujisawa, Mu¨nchen, Ger-
many) at final concentrations of 0.5, 5, 50, 500 and 5000
mg/liter. Cell culture medium was exchanged after two days,
and the supernatants from the last three days were col-
lected into EDTA containing tubes, and immediataley
frozen. For controls, cells were cultured in culture medium
alone and in cell culture medium containing ethanol con-
centrations equivalent to 5000 mg/liter CsA (ethanol
0.0035%) or 5000 mg/liter tacrolimus (ethanol 0.08%).
Three different experiments were done in three wells each.
To investige the effect of renotropic factors, PT-1 cells
were incubated for five days (in culture medium containing
5% FCS) with recombinant human hepatocyte growth
factor or epidermal growth factor (10210, 1029, 1028 mol/
liter; R&D Systems, Wiesbaden, Germany). In addition,
PT-1 cells were coincubated with CsA or tacrolimus (50
and 500 mg/liter) and HGF or EGF (1028 mol/liter). Two
experiments were done in three wells each. Cell culture
medium was exchanged after two days, and the cell culture
medium from the last three days was collected for deter-
mination of ET-1 and ET-3.
Measurement of immunoreactive endothelin-1 and
endothelin-3
ET-1 and ET-3 concentrations in cell culture superna-
tants were determined after solid phase extraction. Sep Pak
C18 cartridges (Waters, Eschborn, Germany) were pre-
washed successively with 100% methanol, distilled water,
and 4% acetic acid. Samples were acidified with 4% acetic
acid and applied to the cartridges. After applying the
samples, the columns were washed with 25% ethanol, and
the absorbed peptides were eluted by a solution containing
86% ethanol and 4% acetic acid. The eluate was dried in a
centrifugal vacuum concentrator and suspended in radio-
immunoassay buffer. The recovery was determined by
addition of the cold peptide: ET-1, 83.7 6 11.2%; ET-3,
78.4 6 9.7% (N 5 10).
ET-1 and ET-3 were measured using radioimmunoassay
kits purchased from Phoenix Pharmaceuticals (cross reac-
tivities were, for the ET-1 assay, ET-1 100%, ET-2 7%,
ET-3 7%; for the ET-3 assay, ET-3 100%, ET-1 0.1%, ET-2
0.1%). Standards or samples (100 ml) were incubated with
100 ml of rabbit anti-ET-1 or anti-ET-3 antibody overnight
at 4°C. The following day, 100 ml of 125I-labeled ET-1 or
ET-3 were added. After overnight incubation at 4°C, goat
anti-rabbit immunoglobulin and normal rabbit serum were
added, followed by an incubation period of 90 minutes at
room temperature. After addition of 500 ml radioimmuno-
assay buffer, samples were centrifuged (3000 rpm, 20 min),
supernatants were decanted, and the pellets were counted
in a gamma-counter. All standards and samples were
measured in duplicate. Intra-assay coefficients of variation
(N 5 16) were 7.4% (ET-1) and 6.3% (ET-3), and inter-
assay coefficients of variation (N 5 6) were 11.1% and
9.7%, respectively. No immunoreactive endothelin was
detected in cell culture medium that had not been incu-
bated with the cells.
Investigation of cell viability
The activity of lactate dehydrogenase was determined in
cell culture supernatants of PT-1 cells, incubated for five
days with CsA or tacrolimus (0.5 to 5000 mg/liter), by a
routine assay, measuring the decrease of absorbance at 340
nm, resulting from the conversion of NADH to NAD in the
presence of pyruvate.
PT-1 cells, seeded on to glass slides, were incubated with
cell culture medium containing 5% FCS and 500 or 5000
mg/liter CsA or tacrolimus, and after three days, cells were
incubated with fluorescein diacetate (10 mg/ml, 1 min at
room temperature; Sigma, Deisenhofen, Germany) or pro-
pidium iodide (1 mg/ml, 5 min at room temperature;
Sigma). Viable cells that could hydrolyse fluorescein diac-
etate exhibited a green fluorescent staining of cytoplasm.
Toxically damaged cells exhibited a red fluorescent staining
of nuclei after incubation with propidium iodide.
Statistical analysis
Results are expressed as means 6 SEM. ET-1 and ET-3
release are given as pg/106 cells, referred to the cell number
at the time point of supernatant collection. Differences
between the endothelin release into the basolateral and
apical compartment in PT-1 cells, cultured with either 1%
or 10% FCS as well as the influence of different concen-
trations of CsA and tacrolimus and the influence of growth
factors on ET-1 and ET-3 release were evaluated by one
way analysis of variance, followed by the Newman-Keuls
test.
RESULTS
Endothelin-1 and endothelin-3 mRNA expression in
proximal tubule cells
Investigation of ET-1 and ET-3 mRNA expression in
PT-1 cells, maintained in cell culture medium containing
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5% FCS, exhibited bands of 440 base pairs and 276 base
pairs that corresponded to the predicted amplified se-
quences for ET-1 and ET-3 (Fig. 1). No detectable PCR
products were present in water controls and in controls,
amplified without prior reverse transcription.
Detection of immunoreactive endothelin-1 and
endothelin-3 in proximal tubule cells
Immunofluorescence staining of cultured rabbit proximal
tubule cells grown on glass slides with antibodies against
ET-1 and ET-3 revealed an intense perinuclear staining
(Fig. 2). No significant immunoreactive staining was ob-
served in controls, using anti-ET-1 and anti-ET-3 antibod-
ies, prereacted with the corresponding peptides, or pre-
immune serum instead of the primary antibody.
Time course of endothelin-1 and endothelin-3 release by
proximal tubule cells
The time course of ET-1 and ET-3 release was investi-
gated in PT-1 cells, cultured in medium containing 5%
FCS. Supernatants were collected after different incuba-
tion periods (N 5 3). ET-1 release increased up to an
incubation period of 36 hours, whereas ET-3 release had
already reached a steady state level after an incubation
period of four hours, which, however, was lower than the
maximum ET-1 release (Fig. 3).
Investigation of polar endothelin-1 and endothelin-3
secretion by proximal tubule-1 cells
PT-1 cells, grown on filter membranes in cell culture
medium supplemented with either 1% or 10% FCS, re-
leased a significantly higher amount of immunoreactive
ET-1 into the basolateral compartment than into the apical
compartment, whereas no significant difference between
basolateral and apical ET-3 release was observed. ET-1
release into the basolateral and apical compartment was
significantly increased in PT-1 cells grown in culture me-
dium supplemented with 10% FCS compared to PT-1 cells
grown in culture medium containing 1% FCS. In contrast,
the stimulatory effect of FCS on ET-3 release was less
pronounced. Data are shown in Figure 4.
Effect of cyclosporine A and tacrolimus on endothelin-1
and endothelin-3 release
Incubation of PT-1 cells with CsA and tacrolimus over
five days induced a dose-dependent stimulation of ET-1
and ET-3 release into the cell culture medium with a
maximum stimulation at CsA concentrations of 500 mg/liter
and tacrolimus concentrations of 50 mg/liter. Results are
shown in Figures 5 and 6 and represent the relative ET-1
and ET-3 release compared to ethanol containing controls.
ET-1 and ET-3 release did not differ significantly between
non-alcohol and alcohol controls (CsA, 0.0035%; tacroli-
mus, 0.08%; ET-1 without ethanol 116.1 6 12.5; ET-1 with
0.0035% ethanol, 115.7 6 14.7; ET-1 with 0.08% ethanol,
114.4 6 15.8; ET-3 without ethanol, 41.9 6 3.5, ET-3 with
0.0035% ethanol, 42.5 6 2.2, ET-3 with 0.08% ethanol,
40.2 6 3.4 pg/106 cells).
To determine whether the decrease of ET-1 and ET-3
release at a CsA concentration of 5000 mg/liter and at
tacrolimus concentrations of 500 and 5000 mg/liter might
have been due to a cytotoxic effect, LDH activity was
determined in supernatants, and cells were stained with
fluorescein diacetate and propidium iodide. LDH activity
did not differ significantly between controls and superna-
tants of PT-1 cells, incubated with CsA 0.5 to 500 mg/liter or
tacrolimus 0.5 to 5 mg/liter, but was significantly elevated in
culture medium of PT-1 cells incubated with 5000 mg/liter
CsA (59.7 6 2.3 U/liter, P , 0.001) and 500 or 5000 mg/liter
tacrolimus (33.0 6 1.4 U/liter, 40.0 6 1.2 U/liter, P , 0.01)
compared to controls (23.3 6 1.2 U/liter). A positive
cytoplasmatic staining with fluorescein diacetate was ob-
served in about 100% of control cells (5% FCS), and about
90% and 95% of the cells incubated with CsA or tacroli-
mus. Only very few of the control cells, and about 5 to 10%
of PT-1 cells incubated with 500 mg/liter CsA exhibited a
positive labeling with propidium iodide, whereas about 20
to 40% of PT-1 cells incubated with 5000 mg/liter CSA or
500 and 5000 mg/liter tacrolimus showed a nuclear immu-
nofluorescence staining.
Fig. 1. Detection of endothelin (ET)-1 and ET-3 mRNA by RT-PCR in
rabbit proximal tubule cells, grown in culture medium containing 5% fetal
calf serum. Ethidium bromide stained PCR products in 1% agarose gel.
Arrows indicate the PCR products of the predicted size of 440 bp for ET-1
mRNA (lane 2) and 276 bp for ET-3 mRNA (lane 3). The left lane is a 100
bp DNA ladder.
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Inhibitory action of renotropic factors on endothelin-1
release
Incubation of PT-1 cells with HGF and EGF (10210 to
1028 mol/liter) for five days induced a significant (P ,
0.001) dose-dependent reduction of ET-1 release com-
pared to controls, whereas ET-3 release was not signifi-
cantly reduced (controls, ET-1 134.3 6 8.5, ET-3 47.7 6
5.3, pg/106 cells, N 5 6). Data are shown in Figures 7 and
8.
Coincubation of PT-1 cells with CsA or tacrolimus (50
and 500 mg/liter) and HGF (1028 mol/liter) for five days
induced a strong reduction of ET-1 release to values similar
to those obtained with HGF alone. No significant inhibitory
effect on ET-3 release was observed. Coincubation with
CsA or tacrolimus and EGF (1028 mol/liter) also induced a
significant reduction of ET-1 release, and only a slight
reduction of ET-3 release. Results are shown in Figures 9
and 10.
DISCUSSION
In the present study, we have demonstrated that cultured
rabbit proximal tubule cells express ET-1 and ET-3 mRNA,
exhibit a positive immunofluorescence staining with anti-
bodies against ET-1 and ET-3, and secrete ET-1 and ET-3
into the cell culture medium. A time-dependent increase of
ET-1 release up to an incubation period of 36 hours was
observed, whereas the ET-3 release had already reached a
steady state level after four hours. PT-1 cells released
immunoreactive ET-1 predominantly into the basolateral
compartment. The basolateral and the apical ET-1 release
was significantly increased when cells were incubated in cell
culture medium containing 10% FCS, compared to 1%
FCS. In contrast, ET-3 release did not differ significantly
between the basolateral and the apical compartments, and
the stimulation by FCS was less pronounced. The current
findings of a polar ET-1 secretion by PT-1 cells are in
accordance with previous studies performed with rabbit
proximal tubule cells [9], rat inner medullary collecting duct
cells [29], mouse cortical and medullary collecting duct cell
lines [8], and a cell line originating from dog collecting duct
[30]. A dose-dependent stimulatory effect of FCS on ET-1
release has been observed in experiments with rat inner
Fig. 2. Immunofluorescence staining of rabbit
proximal tubule cells with antibodies against
endothelin (ET)-1 (A) and ET-3 (B). Original
magnification 31000.
Fig. 3. Endothelin-1 (f) and endothelin-3 (n) release by cultured rabbit
proximal tubule cells, incubated for different time periods in cell culture
medium containing 5% FCS. Data are means 6 SEM, N 5 3.
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medullary tubule suspensions [31]. In addition to previous
studies on ET-1 secretion, the present data provide support
for a different regulation of ET-1 and ET-3 release, by
demonstrating a non-polar secretion of ET-3, a different
time course of ET-1 and ET-3 release, and a different
stimulatory effect of FCS on ET-1 and ET-3 release by
rabbit proximal tubule cells.
Several studies have suggested that ET-1 plays an impor-
tant role in mediating the nephrotoxic side effects of CsA
and tacrolimus. Application of CsA has been demonstrated
to induce a vasoconstriction in isolated rat renal afferent
arterioles, which was antagonized by the application of a
selective ETA receptor antagonist [32]. In addition, several
in vivo studies have shown a protective effect of ETA
Fig. 4. Basolateral (bas.) and apical (ap.)
endothelin-1 (A, dark grey columns) and
endothelin-3 (B, light grey columns) release by
proximal tubule (PT-1) cells, grown on filter
membranes in culture medium containing 1%
or 10% FCS. Data are means 6 SEM, N 5 6.
***P , 0.001 versus apical endothelin-1
release, 111P , 0.001 compared to endothelin-
1 release by PT-1 cells, cultured in medium
containing 1% FCS (basolateral vs. basolateral,
apical vs. apical), 1P , 0.05 11P , 0.01
compared to endothelin-3 release by PT-1 cells,
cultured in medium containing 1% FCS
(basolateral vs. basolateral, apical vs. apical).
Fig. 5. Effect of cyclosporine A on endothelin-1
(A) and endothelin-3 (B) release by cultured
rabbit proximal tubule cells. Data are means 6
SEM, N 5 9, *P , 0.05 **P , 0.01 ***P ,
0.001 versus control.
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receptor antagonists on the cyclosporine-induced renal
dysfunction [13, 33]. In cell culture experiments, cyclospor-
ine has been shown to exhibit a stimulatory effect on ET-1
production by human and rabbit endothelial cells [16, 34,
35], rat vascular smooth muscle cells [36], rat mesangial
cells [17, 18], and by the renal cell line LLC-PK1 [37].
Similarly, a stimulatory effect of tacrolimus on ET-1 release
by cultured human endothelial cells [34], human and rat
mesangial cells [38, 39] and by the LLC-PK1 tubular cell
line [38] has been described. In the present study, a
dose-dependent stimulatory effect of CsA and tacrolimus
on ET-1 and ET-3 release by rabbit proximal tubule cells
with a maximum stimulation at a CsA concentration of 500
mg/liter and a tacrolimus concentration of 50 mg/liter was
Fig. 6. Effect of tacrolimus on endothelin-1 (A)
and endothelin-3 (B) release by cultured rabbit
proximal tubule cells. Data are means 6 SEM,
N 5 9, *P , 0.05 ***P , 0.001 versus control.
Fig. 7. Effect of hepatocyte growth factor
(HGF) on endothelin-1 (A) and endothelin-3
(B) release by cultured rabbit proximal tubule
cells. Data are means 6 SEM, N 5 6, ***P ,
0.001 versus control.
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observed. Consistent with the decrease of ET-1 and ET-3
release at a CsA concentration of 5000 mg/liter and at
tacrolimus concentrations of 500 and 5000 mg/liter, a
significant increase of lactate dehydrogenase (LDH) re-
lease and a deterioration of cell viability has been shown.
The maximum CsA concentration used in this study was
about 25- to 50-fold higher than the therapeutic range of
circulating concentrations in patients with chronic cyclo-
sporine administration; however, it has been suggested that
tissue levels of the lipophilic substances CsA or tacrolimus
Fig. 8. Effect of epidermal growth factor
(EGF) on endothelin-1 (A) and endothelin-3
(B) release by cultured rabbit proximal tubule
cells. Data are means 6 SEM, N 5 6, **P ,
0.01 ***P , 0.001 versus control.
Fig. 9. Endothelin-1 (A) and endothelin-3 (B)
release by proximal tubule (PT-1) cells,
coincubated with cyclosporine A and hepatocyte
growth factor (HGF, 1028 mol/liter) or
epidermal growth factor (EGF, 1028 mol/liter).
Data are means 6 SEM, N 5 6, ***P , 0.001
versus cyclosporine 50 mg/liter, 11P , 0.01 and
111P , 0.001 versus cyclosporine 500 mg/liter.
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might be up to about 50-fold higher than blood concentra-
tions [40, 41]. To compare the effects of CsA and tacroli-
mus, tacrolimus was also used in the same concentrations,
although the therapeutic range of tacrolimus is about
tenfold lower than the therapeutic range of CsA. In a
recently published study, a five day incubation of cultured
human renal cortical epithelial cells with 2,000 mg/liter CsA
induced an increase of ET-1 release, whereas at a CsA
concentration of 10,000 mg/liter no more stimulatory effect
on ET-1 release was observed [19]. In another study
investigating the effect of tacrolimus on ET-1 release by the
LLC-PK1 tubular cell line, after incubation periods of 20
and 30 hours the stimulatory effect of 1 mM tacrolimus (800
mg/liter) was less pronounced than the stimulatory effect of
0.1 mM tacrolimus (80 mg/liter) [38].
At present, the physiological or pathophysiological role
of tubular endothelin synthesis is not yet fully understood.
An increased proximal tubular endothelin production
might by paracrine mechanisms be involved in mediating
the CsA- and tacrolimus-induced renal hypoperfusion. This
effect might be enhanced by an autocrine stimulation of
endothelin production. An autoinduction of ET-1 has been
obeserved in human proximal tubule cells [42] and rat
mesangial cells [3]. It has also been speculated that an
enhanced endothelin production by autocrine mechanisms
might be involved in mediating cyclosporine-associated
tubular structural damage. However, until now this remains
unclear, and previous animal studies have yielded contra-
dictory results [43, 44].
Renotropic factors, such as hepatocyte growth factor and
epidermal growth factor, have been shown to act as mito-
gens for proximal tubule cells and accelerate tubular regen-
eration after drug-induced and ischemic injury [20–24, 26].
In the current study, HGF and EGF exhibited a significant
dose-dependent inhibitory effect on ET-1 release by PT-1
cells, whereas ET-3 release was not significantly reduced.
The CsA- and tacrolimus-induced ET-1 release was also
significantly reduced by HGF and EGF. Interestingly, HGF
has recently been shown to exert a preventive effect on the
degenerative changes in renal tubular cells of cyclosporine-
treated mice [45] and the tacrolimus-induced nephrotoxic-
ity in rats [46]. Thus, it is speculated that the protective
effect of renotropic factors might be mediated in part by
their inhibitory effect on endothelin release.
In summary, the present data suggest that ET-1 and
ET-3 release by rabbit proximal tubule cells is regulated by
different mechanisms. CsA and tacrolimus have been
shown to exert a dose-dependent effect on ET-1 and ET-3
release by rabbit proximal tubule cells. The present findings
of an inhibitory effect of HGF and EGF on the basal and
CsA- and tacrolimus-induced ET-1 release suggest that the
renoprotective effects of HGF and EGF might be linked to
their modulatory effect on endothelin production.
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APPENDIX
Abbreviations used in this article are: CsA, cyclosporine A; EGF,
epidermal growth factor; ET, endothelin; FCS, fetal calf serum; HGF,
hepatocyte growth factor; LDH, lactate dehydrogenase; RT-PCR, reverse
transcription-polymerase chain reaction.
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